Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence Joly

Showing results (191-200 of 347) with videos related to

Pageof 35
Sort By:
Gynecologic Oncology|December 15, 2022
Response to first line platinum-based chemotherapy in mismatch repair deficient (MMRd)/ microsatellite instability high (MSI-high) endometrial carcinomaEmeline Colomba, Jérôme Alexandre, Gwénaël Le Teuff, et al.
BMC Cancer|October 10, 2020
Feasibility and efficacy of a supervised home-based physical exercise program for metastatic cancer patients receiving oral targeted therapy: study protocol for the phase II/III - UNICANCER SdS 01 QUALIOR trialFlorence Joly, Claudia Lefeuvre-Plesse, Claire Garnier-Tixidre, et al.
BMC Cancer|February 1, 2018
Correction to: Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocolMarie Lange, Heidi Laviec, Hélène Castel, et al.
European Journal of Cancer (Oxford, England : 1990)|June 25, 2014
Baseline cognitive functions among elderly patients with localised breast cancerMarie Lange, Bénédicte Giffard, Sabine Noal, et al.
Therapeutic Advances in Urology|March 1, 2024
Carboplatin in metastatic castration-resistant prostate cancer patients with molecular alterations of the DNA damage repair pathway: the PRO-CARBO phase II trialElodie Coquan, Nicolas Penel, Justine Lequesne, et al.
Clinical Genitourinary Cancer|February 21, 2017
Prediction of Everolimus Toxicity and Prognostic Value of Skeletal Muscle Index in Patients With Metastatic Renal Cell CarcinomaEdouard Auclin, Camille Bourillon, Eleonora De Maio, et al.
European Journal of Cancer Care|September 24, 2020
Evaluation of long-term living conditions in patients treated for localised prostate cancerDingyu Xiao, Anne-Valérie Guizard, Laetitia Daubisse-Marliac, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2014
Patient-reported outcome results from the open-label phase III AURELIA trial evaluating bevacizumab-containing therapy for platinum-resistant ovarian cancerMartin R Stockler, Felix Hilpert, Michael Friedlander, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 7, 2020
Expectations and preferences of patients with primary and relapsed ovarian cancer to maintenance therapy: A NOGGO/ENGOT-ov22 and GCIG survey (Expression IV)Irena Rohr, Sara Alavi, Rolf Richter, et al.
Communications Medicine|December 23, 2025
Impact of androgen receptor pathway inhibitors on cognitive function in older adults treated for metastatic prostate cancerAntoine Boué, Giulia Baciarello, Emmanuel Meyer, et al.
Pageof 35

Showing results (191-200 of 347) with videos related to

Sort By:
Pageof 35
Gynecologic Oncology|December 15, 2022
Response to first line platinum-based chemotherapy in mismatch repair deficient (MMRd)/ microsatellite instability high (MSI-high) endometrial carcinomaEmeline Colomba, Jérôme Alexandre, Gwénaël Le Teuff, et al.
BMC Cancer|October 10, 2020
Feasibility and efficacy of a supervised home-based physical exercise program for metastatic cancer patients receiving oral targeted therapy: study protocol for the phase II/III - UNICANCER SdS 01 QUALIOR trialFlorence Joly, Claudia Lefeuvre-Plesse, Claire Garnier-Tixidre, et al.
BMC Cancer|February 1, 2018
Correction to: Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocolMarie Lange, Heidi Laviec, Hélène Castel, et al.
European Journal of Cancer (Oxford, England : 1990)|June 25, 2014
Baseline cognitive functions among elderly patients with localised breast cancerMarie Lange, Bénédicte Giffard, Sabine Noal, et al.
Therapeutic Advances in Urology|March 1, 2024
Carboplatin in metastatic castration-resistant prostate cancer patients with molecular alterations of the DNA damage repair pathway: the PRO-CARBO phase II trialElodie Coquan, Nicolas Penel, Justine Lequesne, et al.
Clinical Genitourinary Cancer|February 21, 2017
Prediction of Everolimus Toxicity and Prognostic Value of Skeletal Muscle Index in Patients With Metastatic Renal Cell CarcinomaEdouard Auclin, Camille Bourillon, Eleonora De Maio, et al.
European Journal of Cancer Care|September 24, 2020
Evaluation of long-term living conditions in patients treated for localised prostate cancerDingyu Xiao, Anne-Valérie Guizard, Laetitia Daubisse-Marliac, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2014
Patient-reported outcome results from the open-label phase III AURELIA trial evaluating bevacizumab-containing therapy for platinum-resistant ovarian cancerMartin R Stockler, Felix Hilpert, Michael Friedlander, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 7, 2020
Expectations and preferences of patients with primary and relapsed ovarian cancer to maintenance therapy: A NOGGO/ENGOT-ov22 and GCIG survey (Expression IV)Irena Rohr, Sara Alavi, Rolf Richter, et al.
Communications Medicine|December 23, 2025
Impact of androgen receptor pathway inhibitors on cognitive function in older adults treated for metastatic prostate cancerAntoine Boué, Giulia Baciarello, Emmanuel Meyer, et al.
Pageof 35